Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer
Dr. Yitzhak Peterburg became Teva's Chairman of the Board of Directors on January 1, 2015, after rejoining Teva's Board of Directors in 2012.
Teva Pharmaceutical acquires Gecko Health Innovations
Through this agreement, Teva will acquire CareTRx, Gecko's cloud-based solution designed to simplify chronic respiratory disease management.
Teva Pharmaceuticals invests “tens of millions” in American Well
Teva is committed to attaining a significant presence in the rapidly growing electronic medicine field, so that it can expand its solutions beyond medication.